Xeris Pharmaceuticals | XERS - Current Liabilities

Stock Price
6.05
Daily Change
0.10 1.68%
Monthly
14.15%
Yearly
40.37%
Q2 Forecast
5.92

Xeris Pharmaceuticals reported $109.57M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Celltrion KRW 4.01T 343.96B Sep/2025
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Divis Laboratories Ltd INR 17.28B 2.76B Sep/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Kangmei Pharma CNY 5.81B 57.93M Sep/2025
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Organigram Holdings CAD 94.05M 32.11M Dec/2025
Ovoca Bio EUR 186K 2.26M Jun/2025
Pacira USD 120.59M 13.51M Dec/2025
Perrigo USD 1.01B 132.4M Dec/2025
Pharma Mar EUR 93.88M 4.94M Dec/2025
Qiagen NV USD 512.14M 461.26M Dec/2025
Sartorius EUR 2.11B 145.8M Mar/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Supernus Pharmaceuticals USD 338.17M 7.54M Dec/2025
Tilray USD 259.32M 8.32M Sep/2025
Zealand Pharma A/S 664.96M 513.61M Dec/2025
Zz Pientze Pharmaceu CNY 2.14B 1.06B Sep/2025